Cadrenal Therapeutics (CVKD) Earnings Date & Reports

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVKD is expected to report earnings to rise 47.12% to -152 cents per share on November 05

Cadrenal Therapeutics CVKD Stock Earnings Reports

Q3'26

Est.

$-1.53

Q1'26

Beat

by $0.31

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.08

Q2'25

Missed

by $0.61

The last earnings report on May 07 showed earnings per share of -103 cents, beating the estimate of -135 cents. With 7.54K shares outstanding, the current market capitalization sits at 6.64M.

View a ticker or compare two or three

CVKD

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days